Agios Pharmaceuticals
AGIO
AGIO
215 hedge funds and large institutions have $3.61B invested in Agios Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 65 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 197 → 215 (+18)
5% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 62
3.33% less ownership
Funds ownership: 101.3% → 97.97% (-3.3%)
Holders
215
Holding in Top 10
5
Calls
$28.9M
Puts
$19.2M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$25.5M | |
| 3 | +$18M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$17.3M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
+$16M |
Top Sellers
| 1 | -$181M | |
| 2 | -$20.4M | |
| 3 | -$19.9M | |
| 4 |
HM
HealthCor Management
New York
|
-$14.5M |
| 5 |
Jennison Associates
New York
|
-$10.7M |